资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
Contineum与强生合作的多发性硬化症药物在二期试验中未能改善视力
Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis.
先搜索，再按来源或主题继续收窄。
Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis.